Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Theranostics
|
October 8, 2019
Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
Aurélie Rondon, Sébastien Schmitt, Arnaud Briat, et al.
Scientific Reports
|
November 4, 2017
Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models
Aurélie Rondon, Nancy Ty, Jean-Baptiste Bequignat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy
Clara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.
Investigational New Drugs
|
April 3, 2014
Evaluation of two (125)I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma
Maryline Gardette, Claire Viallard, Salomé Paillas, et al.
Leukemia
|
December 15, 2019
The therapeutic effectiveness of <sup>177</sup>Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest
Alexandre Pichard, Sara Marcatili, Jihad Karam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Emmanuel Deshayes, Riad Ladjohounlou, Pierre Le Fur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
Riad Ladjohounlou, Catherine Lozza, Alexandre Pichard, et al.
Oncotarget
|
April 21, 2017
Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer
Aurelie Maisonial-Besset, Tiffany Witkowski, Isabelle Navarro-Teulon, et al.
Oncotarget
|
April 22, 2017
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
Pauline Estupina, Alexandre Fontayne, Jean-Marc Barret, et al.
Oncoimmunology
|
December 19, 2024
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7<sup>th</sup> immunorad conference
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Theranostics
|
October 8, 2019
Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept
Aurélie Rondon, Sébastien Schmitt, Arnaud Briat, et al.
Scientific Reports
|
November 4, 2017
Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models
Aurélie Rondon, Nancy Ty, Jean-Baptiste Bequignat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy
Clara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.
Investigational New Drugs
|
April 3, 2014
Evaluation of two (125)I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma
Maryline Gardette, Claire Viallard, Salomé Paillas, et al.
Leukemia
|
December 15, 2019
The therapeutic effectiveness of <sup>177</sup>Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest
Alexandre Pichard, Sara Marcatili, Jihad Karam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 21, 2018
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Emmanuel Deshayes, Riad Ladjohounlou, Pierre Le Fur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2019
Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
Riad Ladjohounlou, Catherine Lozza, Alexandre Pichard, et al.
Oncotarget
|
April 21, 2017
Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer
Aurelie Maisonial-Besset, Tiffany Witkowski, Isabelle Navarro-Teulon, et al.
Oncotarget
|
April 22, 2017
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
Pauline Estupina, Alexandre Fontayne, Jean-Marc Barret, et al.
Oncoimmunology
|
December 19, 2024
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7<sup>th</sup> immunorad conference
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
Page
of 7